Immediate Impact
58 standout
Citing Papers
Cancer statistics, 2025
2025 Standout
Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and Management
2025 Standout
Works of Paul Cahalin being referenced
A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Paul Cahalin | 414 | 138 | 190 | 13 | 439 | |
| X. Thomas | 344 | 185 | 137 | 12 | 416 | |
| Maria C. Sauerland | 415 | 116 | 174 | 7 | 433 | |
| Thomas Buechner | 314 | 65 | 202 | 16 | 398 | |
| Ralph Vogler | 285 | 151 | 189 | 19 | 457 | |
| Anna Byrd | 344 | 96 | 183 | 10 | 416 | |
| Jan Davisson | 329 | 92 | 223 | 8 | 443 | |
| Maria Paz Queipo De Llano | 371 | 142 | 209 | 13 | 427 | |
| Anna Evans | 304 | 151 | 160 | 10 | 459 | |
| Jasmijn de Rooij | 278 | 147 | 222 | 15 | 451 | |
| Mirjam Klaus | 338 | 110 | 162 | 10 | 404 |
All Works
Login with ORCID to disown or claim papers
Loading papers...